Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C CHRISTIANSEN

Showing results (741-750 of 757) with videos related to

Pageof 76
Sort By:
Annals of the Rheumatic Diseases|December 13, 2005
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE studyJ-Y Reginster, S Adami, P Lakatos, et al.
Theranostics|February 14, 2022
Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapiesLuman Liu, Prakash G Kshirsagar, Shailendra K Gautam, et al.
Bone|December 14, 2012
Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosisK Henriksen, J R Andersen, B J Riis, et al.
Diabetes, Obesity & Metabolism|December 6, 2021
Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysisOthmar Moser, Christoph Sternad, Max L Eckstein, et al.
JAMA|October 12, 1999
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) InvestigatorsB Ettinger, D M Black, B H Mitlak, et al.
Annals of the Rheumatic Diseases|July 31, 2013
Value of biomarkers in osteoarthritis: current status and perspectivesM Lotz, J Martel-Pelletier, C Christiansen, et al.
Postgraduate Medical Journal|February 19, 2014
Republished: Value of biomarkers in osteoarthritis: current status and perspectivesM Lotz, J Martel-Pelletier, C Christiansen, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2021
Consensus on treatment goals in hereditary angioedema: A global Delphi initiativeMarcus Maurer, Emel Aygören-Pürsün, Aleena Banerji, et al.
Clinical Epigenetics|February 17, 2021
Novel DNA methylation signatures of tobacco smoking with trans-ethnic effectsC Christiansen, J E Castillo-Fernandez, A Domingo-Relloso, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 27, 2007
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and womenJ A Kanis, A Oden, O Johnell, et al.
Pageof 76

Showing results (741-750 of 757) with videos related to

Sort By:
Pageof 76
Annals of the Rheumatic Diseases|December 13, 2005
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE studyJ-Y Reginster, S Adami, P Lakatos, et al.
Theranostics|February 14, 2022
Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapiesLuman Liu, Prakash G Kshirsagar, Shailendra K Gautam, et al.
Bone|December 14, 2012
Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosisK Henriksen, J R Andersen, B J Riis, et al.
Diabetes, Obesity & Metabolism|December 6, 2021
Performance of intermittently scanned continuous glucose monitoring systems in people with type 1 diabetes: A pooled analysisOthmar Moser, Christoph Sternad, Max L Eckstein, et al.
JAMA|October 12, 1999
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) InvestigatorsB Ettinger, D M Black, B H Mitlak, et al.
Annals of the Rheumatic Diseases|July 31, 2013
Value of biomarkers in osteoarthritis: current status and perspectivesM Lotz, J Martel-Pelletier, C Christiansen, et al.
Postgraduate Medical Journal|February 19, 2014
Republished: Value of biomarkers in osteoarthritis: current status and perspectivesM Lotz, J Martel-Pelletier, C Christiansen, et al.
The Journal of Allergy and Clinical Immunology|May 28, 2021
Consensus on treatment goals in hereditary angioedema: A global Delphi initiativeMarcus Maurer, Emel Aygören-Pürsün, Aleena Banerji, et al.
Clinical Epigenetics|February 17, 2021
Novel DNA methylation signatures of tobacco smoking with trans-ethnic effectsC Christiansen, J E Castillo-Fernandez, A Domingo-Relloso, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 27, 2007
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and womenJ A Kanis, A Oden, O Johnell, et al.
Pageof 76